Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KOL Strategy

- PMLiVE

Phytopharm shares dive as Parkinson’s drug fails

Stock falls 80 per cent after Cogane failure in phase II

- PMLiVE

Ironwood promotes Dr Mark Currie

He moves up to chief scientific officer at the US pharma company

- PMLiVE

BMS hires Shire’s Ann Powell Judge to head human resources

She has also served at Wyeth and the Dow Chemical Company

- PMLiVE

NICE recommends test to support choice of breast cancer treatment

Genomic Health’s Oncotype DX could avoid over-treatment using chemotherapy

- PMLiVE

15 years since the first paper published on RNA interference

This month in 1998: Andrew Fire and Craig Mello's breakthrough paper

APCO launch Rotary International campaign to eradicate polio

Public affairs support will cover Europe and Canada

- PMLiVE

Gilead recalls Vistide due to foreign particles

Affected batch of AIDS symptom treatment sold in the US, Europe and Canada

Novartis building

Novartis’ Zortress cleared by FDA for liver transplants

Adds to kidney transplant indication in the US

- PMLiVE

Genzyme on track for eliglustat filing in 2013

Says oral Gaucher disease drug as effective as its injectable Cerezyme

- PMLiVE

Microsoft Kinect could undercut telemedicine systems

Study praises combination of game controller, laptop and cloud computing platform

- PMLiVE

Social innovation in pharma

The use of social media by pharma beyond Facebook and Twitter

- PMLiVE

Larry Bell joins Dutch biopharma Prosensa

Takes up role as head of global regulatory affairs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links